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Abstract
Influenza A viruses are rapidly evolving pathogens with the potential for novel strains to emerge 
and result in pandemic outbreaks in humans. Some avian-adapted subtypes have acquired the 
ability to bind to human glycan receptors and cause severe infections in humans but have yet to 
adapt to and transmit between humans. The emergence of new avian strains and their ability to 
infect humans has confounded their distinction from circulating human virus strains through 
linking receptor specificity to human adaptation. Herein we review the various structural and 
biochemical analyses of influenza hemagglutinin–glycan receptor interactions. We provide our 
perspectives on how receptor specificity can be used to monitor evolution of the virus to adapt to 
human hosts so as to facilitate improved surveillance and pandemic preparedness.
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Glycans as host receptors for influenza A viruses
Influenza A, a zoonotic disease, represents a substantial public health burden, especially in 
the case of epidemic or pandemic outbreaks [1, 2]. Influenza A virus subtypes, found 
naturally in aquatic birds, are identified according to their surface antigens: hemagglutinin 
(HA) and neuraminidase (NA). Novel strains of influenza emerge due to mutations 
(antigenic drift) and reassortment among subtypes (antigenic shift). In random and 
unpredictable instances, predominantly through the process of antigenic shift, altered 
influenza viruses can emerge that efficiently infect humans, are highly transmissible via 
aerosol between humans, and potentially pathogenic, resulting in a pandemic outbreak [3–
6]. Such pandemics have occurred several times in the 20th century, including in 1918 
(H1N1), 1958 (H2N2), and 1967 (H3N2). Among these subtypes, H1N1 and H3N2 have 
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established sustained circulation in the human population (and hence will be referred to as 
human viruses) by underdoing antigenic drift, which results in seasonal flu outbreaks each 
year. More recently even among these human virus subtypes, a novel H1N1 strain in 2009 
emerged from reassortment of viral gene segments among avian, swine, and human viral 
strains and were able to successfully establish circulation via efficient human-to-human 
transmission [7–9].
The previous rapid introduction and spread of novel influenza strains and subtypes in the 
population has increased the surveillance and study of avian-adapted strains that have been 
documented to infect (but not spread in) humans. Of particular interest are the H5N1, 
H7(N2,N7 and N9), and H9(N1 and N2) subtypes. Quite recently in fact, a novel avian-
adapted H7N9 strain emerged in China that caused severe infection and whose fatality was 
around 25% (May 2013 statistics see http://www.who.int/csr/don/2013_05_29/en/) that is 
much higher than the 0.1% observed with seasonal influenza A viruses. Although this 
subtype has not completely adapted yet to humans, it already possesses partial phenotypic 
features characteristic of human adapted-viruses [10–15]. Therefore, the adaptation of avian-
adapted subtypes to the human host poses a constant threat of pandemic outbreak (due to the 
poor preexisting immunity for novel subtypes). Significant effort has been focused on 
determining the genetic determinants for human host adaptation, virulence, and aerosol 
transmissibility [16–18]. The binding specificity of the viral surface HA to sialylated glycan 
receptors (glycans terminated by α-D-N-acetyl neuraminic acid; Neu5Ac) on the host cell 
surface is one of many factors that critically govern adaptation of influenza to the human 
host. Avian virus HA binds with high specificity and affinity to glycans terminated by 
α2→3-linked sialic acid which are found in abundance in the avian gut and lower 
respiratory tract of humans (these glycans will henceforth be referred to as α2→3 glycans or 
avian receptors) [19–22]. Human virus HAs possess characteristic glycan receptor binding 
properties; their HA predominantly binds with high affinity (or avidity) to glycan receptors 
terminated by α2→6-linked sialic acid, which are predominantly expressed in the upper 
respiratory epithelia of humans (these glycans will henceforth be referred to as α2→6 
glycans or human receptors) [21, 23, 24]. The human upper respiratory epithelium is the 
primary target site for infection of human-adapted viruses and is thought to be a prerequisite 
for efficient human-to-human transmission via respiratory droplets. Thus, it appears that 
human adaptation of an HA is associated with a switch in its binding preference from avian 
to human receptors. Notably, this switch is a necessary but not sufficient change required for 
human adaptation, which ultimately involves other genetic modifications within the viral 
genome and emergence of phenotypic characteristics such as efficient respiratory droplet 
transmission in ferret animal models [18].
To address in greater detail the binding of HA to its glycan receptors, advances in the 
synthesis of complex glycan structures have been coupled with technologies to display these 
structures on various glycan array platforms and interrogate HA receptor specificity [25–
27]. Using such technologies, the glycan receptor binding properties has been defined in 
many ways in different studies. For example, some studies using glycan arrays characterize 
glycan receptor binding properties based on the ratio of the number of α2→6 to α2→3 
sialylated glycans that bind to a specific HA or virus analyzed at a high titer or concentration 
[23, 28]. Other studies have defined binding specificity based on the ratio of binding affinity 
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(or avidity) of HA (or virus) to α2→6 vs. α2→3 glycans [29, 30]. A meaningful comparison 
of binding signals from glycan arrays will be to compare across glycans with similar or 
common substructures and linkers that link them to the array surface. The varied 
descriptions of glycans and their linker structures within and across array platforms make 
this process more tedious at the present time.
In parallel with these advances, efforts have been ongoing to routinely solve co-crystal 
structures of HA–glycan complexes for a variety of HA subtypes, including H1, H2, H3, H5, 
H7, and H9 [28, 31–39]. Detailed structural information has provided a wealth of 
information on key interactions within the glycan-receptor binding site (RBS) of HA with 
surrogates of either avian or human receptors or both, leading to the identification of 
hallmark residues that distinguish binding of HAs to both avian and human receptors.
Despite the valuable information offered by these studies, there still remain key unanswered 
questions to our understanding of HA–glycan specificity. For example, it is difficult to 
assess the effect of hallmark residues on avian and human-receptor binding in the context of 
natural sequence evolution of HA. Introducing amino acid changes in different natural 
strains of H5 HA based on prototypic amino acids that contribute to human receptor-binding 
human virus HAs results in drastically different glycan binding properties unrelated to the 
human receptor binding preference [40, 41]. It has been difficult as well to link prototypic 
glycan-array based receptor binding properties of HA with the physiological tissue tropism; 
for example, as is seen in the recently emerged H7N9 HA [14]. Finally, the varying 
definitions of glycan receptor binding have complicated the distinction between binding of 
human and avian virus HA to human receptors. The human virus HA binding to human 
receptors is one of the factors that distinguish the efficient aerosol transmission of human 
virus from the lack of such transmission of avian virus [18].
In the context of the above questions, herein we review the current tools to structurally and 
biochemically characterize HA–glycan interactions. We also offer our perspective how 
human receptor specificity can be benchmarked as a tool for monitoring the evolution of 
avian virus HAs. The eventual goal enabled by this understanding is to improve surveillance 
methods to advance preparedness in the event of emergence of novel influenza strains, 
enabling implementation of countermeasures that can avoid or mute future epidemics or 
pandemics.
HA–glycan receptor interactions: structural and biochemical aspects of 
receptor specificity
Glycan receptor conformation and overall topology in RBS of HA
Several X-ray crystallographic structures of HA–glycan receptor complexes have been 
solved [28, 31–39]. Notably, the most commonly used glycans to represent avian and human 
receptors, respectively are LS-tetrasaccharide a (or LSTa; 
Neu5Acα2-3Galβ1-3GlcNAcβ1-3Galβ1-4Glc) and LS-tetrasaccharide c (or LSTc; 
Neu5Acα2-6Galβ1-4GlcNAcβ1-3Galβ1-4Glc) where Gal, GlcNAc and Glc are 
abbreviations for the hexopyranose sugars D-galactose, N-acetyl-D-glucosamine and D-
glucose respectively. Based on some of the earliest X-ray co-crystal structures, the 
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conformations of LSTa and LSTc have been characterized primarily by the glycosidic 
torsion angles of the terminal sialic acid linkage [20] (Figure 1A). In the case of the 
Neu5Acα2-3Gal-linkage in LSTa complexed with avian-adapted HA, the torsion angle φ 
(C1-C2-O-C3) is ~180° and is described as the trans conformation. In the trans 
conformation the glycosidic oxygen is pointed towards the base of the RBS. In contrast, the 
Neu5Acα2-6Gal linkage in LSTc complexed with human-adapted HA, φ (C1-C2-O-C6), is 
~ −60°, or a cis conformation. In this conformation the glycosidic oxygen points away from 
the base of the RBS and the C6 atom of the penultimate Gal sugar points towards the base of 
the RBS.
The cis and trans definition of glycan receptor conformation enabled distinguishing key 
contacts of residues within the RBS to either LSTa or LSTc, leading to the concept of 
‘hallmark’ residues within the RBS of avian- and human-adapted HAs. In the case of avian-
adapted HAs, residue Glu-190 and Gln-226 (residue numbering based on H3 HA throughout 
the text) are hallmark residues wherein Glu-190 is positioned to interact with sialic acid and 
Gln-226 in the base of the RBS is positioned to make ionic contacts with the glycosidic 
oxygen of Neu5Acα2-3Gal in the trans conformation [20]. In the case of human-adapted 
H2N2 and H3N2 HAs, the 226-position typically has a hydrophobic residue such as Leu, Ile 
or Val, which facilitates hydrophobic interactions with the C6 atom of Neu5Acα2-6Gal in 
the cis conformation [20]. Additionally, the presence of a hydrophobic residue in the 226-
position does not enable favorable contacts with the glycosidic oxygen of Neu5Acα2-3Gal 
and hence is detrimental for avian-receptor binding. Therefore, the Gln226→Leu amino acid 
change has been considered a hallmark mutation for switching the receptor preference 
(leading to human adaptation) for H2 and H3 HAs.
On the other hand, both avian- and human-adapted H1 HAs have Gln-226, which based on 
the RBS structure of this subtype is not favorable for hydrophobic contacts with the C6 atom 
of Neu5Acα2-6Gal. Instead, an Asp in the 225-position (which is typically a Gly in avian-
adapted H1 HAs) in human-adapted H1 HA provides additional contacts with the 
penultimate Gal sugar in the trans conformation [20, 33, 39]. In H1 HA, the differences in 
contacts between avian- and human-receptors go beyond the distinct contacts with 
Neu5Acα2-6Gal and Neu5Acα2-3Gal in the base of the RBS. Another amino acid typically 
observed in human-adapted H1 HA is Asp-190, which favors specific contacts with the third 
GlcNAc sugar (from the non-reducing end) which is not the case with Glu-190, which is 
typically present within avian-adapted HAs [20, 33]. Therefore the Glu vs. Asp in the 190-
position in H1 HA likely plays a key role in distinguishing avian and human receptor 
specificity [42]. Consequently, in H1 HA, Glu190→Asp and Gly225→Asp have been 
considered as hallmark amino acid changes to switch receptor specificity leading to human 
adaptation [42, 43].
While, the cis and trans definition of glycan conformation has been useful to characterize 
the distinct interactions with the terminal Neu5Ac α2→3Gal or Neu5Ac α2→6Gal motif, 
this definition does not fully describe HA binding to a range of structurally diverse glycans, 
either present on glycan array platforms or present in glycomic analysis of human 
respiratory cells and tissues [24]. This limitation motivated studies that revisited the 
definition of glycan conformation, extending the conformational analysis beyond the 
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terminal sialic acid linkage to describe overall topology and dynamics of the glycan receptor 
upon binding to the RBS of avian and human-adapted HAs [24, 44]. To capture this 
topology, a parameter, θ, has been defined to measure the angle between the Neu5Ac, the 
penultimate Gal and the third GlcNAc sugar (measured using anomeric carbon atoms as 
shown in Figure 1B). The θ parameter permits classification of the ensemble of 
conformations sampled by the avian and human receptors within the HA binding site.
In the case of avian receptors, the conformations sampled by the Neu5Acα2→3Gal linkage 
(keeping the Neu5Ac anchored) and the sugars beyond this linkage (at the reducing end) 
span a region on the binding surface of HA that resemble a cone. Therefore the term cone-
like topology has been used to capture the ensemble of these conformations - characterized 
by a θ angle > 110°. The different conformations sampled by Neu5Acα2→6Gal linkage 
(keeping the Neu5Ac anchored) and the sugars beyond this linkage (at the reducing end) 
span a wider area on the HA binding surface [24]. A portion of these RBS-receptor contacts 
can be described as a cone-like surface, whereas the other portion is more correctly 
described as umbrella-like, and is characterized by θ angle <100°. Given the 
conformationally more flexible form, depending on the attributes of the HA RBS and the 
receptor sequence, the umbrella-like conformation ensemble can be fully folded (θ ~ 45°) to 
fully open (θ ~90°) [24]. Regardless, the stem of the umbrella is defined by the 
Neu5Acα2-6Gal- motif and the spokes of the umbrella are occupied by monosaccharides at 
the reducing end of Gal.
Examination of a range of avian-adapted HAs indicate that the defining characteristic of a 
cone-like topology is that the majority of contacts with the HA RBS are through a three-
sugar (or trisaccharide) (Neu5Acα2→3/6Galβ1→3/4GlcNAc-) motif as well as 
monosaccharide substitutions such as O-sulfation (of Gal or GlcNAc) or fucosylation (at 
GlcNAc). On the other hand, the umbrella-like topology was such that monosaccharides 
beyond a trisaccharide make substantial contacts with the HA RBS. Using these shape-based 
definitions of the flexible glycan conformation, it was shown that the umbrella-like topology 
is predominantly adopted by human receptors which possessed at least 4 sugars including 
Neu5Ac, for example, poly-lactosamine branches terminated by α2→6-linked Neu5Ac 
(referred to as long α2→6). The cone-like topology was shown to be adopted by both avian 
and human receptors [24].
Taken together, the shape- or topology-based definitions of glycan receptor conformation 
have been able to provide additional structural perspectives on HA–glycan interactions in 
the context of glycan diversity going beyond terminal sialic acid linkage. Furthermore, this 
framework has led to the identification of additional key residue positions within the RBS of 
different HA subtypes that are involved in binding to avian and human receptors [24, 44]. 
Finally, in conjunction with experimental information (detailed below), this structural 
framework has enabled robust classification of avian and human receptors.
Measuring and characterizing HA–glycan interactions
As is the case with many virus-receptor interactions, binding between HA receptor is 
multivalent. A variety of biochemical methods have been used to characterize the specificity 
in the context of multivalent HA–glycan interactions (see review by Shriver et al. [45] for an 
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overview of these methods). Among the various tools, glycan array platforms are rapidly 
emerging as a popular tool to probe finer nuances of glycan structures that are recognized by 
various HAs [25–27].
Glycan platforms consist of hundreds of synthetic glycan motifs (typically present on N- and 
O-linked glycoproteins and glycolipids) displayed on the surface of the array. Multiple types 
of arrays have been developed that utilize different strategies including the formation of 
neoglycolipids [46–48], neoglycoproteins [49], or the direct application of glycans to 
various surfaces [26, 50–55]. Studies have also begun to adapt these technologies towards 
the presentation of natural glycans by harvesting glycans from the cells or tissues and 
imprinting these on a glycan array format [56, 57], thus allowing one to probe the glycan 
repertoire of a biological system.
Both whole viruses and recombinantly expressed trimeric HA units have been analyzed on 
glycan array platforms. While analysis of viruses on glycan arrays permits obtaining 
qualitative binding characteristics and offers a better chance for identifying binding to low-
affinity glycan ligands, it is exigent, for two major reasons, to quantify these interactions so 
as to compare binding properties across different viruses. First, unless directly labeled, virus 
concentration is commonly expressed as hemagglutination units (HAU) based on the virus’s 
ability to agglutinate red blood cells. This is not a true measure of concentration; depending 
on agglutination potential of a virus, an HAU value could correspond to a very different 
concentration of HA. Emphasizing this fact, glycomic analysis of red blood cells has shown 
that the glycans on red blood cells do not necessarily recapitulate those observed in human 
respiratory cells [58]. Thus, viruses that bind well to human respiratory tissue may 
nonetheless fail to agglutinate red blood cells [58]. Second, depending on the morphology of 
the virus, the distribution of the trimeric HAs vary between different viruses. In turn, the 
differences in distribution of the trimeric HA units impinge on the avidity of glycan binding.
In contrast, analyzing recombinantly expressed turmeric HA units offers a means to 
circumvent these challenges. First, HA concentration can be precisely measured. Also, an 
approach to precomplex the trimeric HA unit with primary and secondary antibodies (in 
HA:primary:secondary ratio of 4:2:1) prior to analysis on glycan array enables one to 
address issues associated with multivalency [25, 59]. Due to the stoichiometry of the 
precomplex, this approach ensures that the predominant species in the analyte corresponds 
to four HA trimeric units that are spatially constrained relative to each other (due to the 
antibody interactions). The apparent affinity constant defined by such an assay can be used 
to compare quantitative binding of different HAs analyzed. Notably, this parameter does not 
have any independent significance from the standpoint of physical chemistry.
A survey of studies completed to date indicates that the scope of array-binding assays varies 
across different studies. In many studies, glycan arrays are used as a primary screen for 
qualitatively analyzing the frequency and type of α2→3 and α2→6 glycans that demonstrate 
binding to recombinant HA (or whole virus). In these studies, glycan-binding specificity is 
defined on the basis of the ratio of α2→6 to α2→3 glycans that show binding signals. This 
type of a screening approach, while informative, does not offer quantitative information, 
particularly relating to the relative human and avian receptor-binding affinity of an HA. 
Raman et al. Page 6
Trends Microbiol. Author manuscript; available in PMC 2015 November 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Quantitative studies focus on selection of a small sampling of glycans representative of 
avian and human receptor and performing a dose response curve by varying either HA 
(virus) concentration or glycan concentration [30, 47, 59, 60]. The trade-off of using this 
approach is, of course, the loss of information regarding the diversity of glycan structures 
that are recognized by a given HA.
Although glycan array platforms display hundreds of diverse glycan structures, they still 
likely do not capture the physiological context or diversity of glycan receptors encountered 
by influenza A viruses in human or animal models. This issue has been addressed in part by 
examining binding of HA or whole virus to tissue sections of the respiratory tract of humans 
(upper respiratory tract:pharynx and trachea; middle respiratory tract: bronchus; and lower 
respiratory tract:alveolar) and/or animal models, such as mice, ferrets, or pigs [21, 22, 24, 
61, 62]. Plant lectins such as SNA-I (specifically binds to α2→6 glycans), MAL-II (shows 
binding to α2→3 glycans), Jacalin (marker for O-linked mucin glycans), and Con A 
(marked for N-linked glycans) can be used to characterize the glycans present in these 
sections and hence provide structural information on HA recognition. Additionally, 
analytical tools such as mass spectrometry have been used to perform detailed structural 
characterization of sialylated glycans isolated from the respiratory tissues and cell lines [24, 
63, 64].
Avian-adapted viruses and HA extensively stain the alveolar sections in the human lower 
respiratory tract that predominantly express avian receptors [22]. On the other hand, human-
adapted viruses and HA show characteristic binding to apical surface of human tracheal 
sections that predominantly express human receptors [21, 24, 62]. Also within the human 
respiratory epithelium, avian-adapted viruses have been shown to primarily infect ciliated 
cells while human-adapted viruses have been shown to infect non-ciliated cells [65]. This 
cell tropism may be important to the physiology of influenza transmission, especially for 
human-adapted viruses. Binding to non-ciliated, goblet cells, especially those with heavily 
glycosylated mucins on their surface, may play a role in droplet formation and transmission.
It is clear that these tools provide diverse yet related information on HA–glycan interactions. 
Therefore, integration of information from analysis of HA or virus binding to glycan arrays 
and physiological tissues can provide additional information beyond that available in arrays, 
including tropism of HA. In our view, integrated information from both tissue staining and 
array analysis provides the most detailed biochemical information on HA–glycan 
interactions that is best suited to phenotypic characterization of HA. To ensure accurate 
assessment of results, an important step is to benchmark the measurements made to 
prototypic human-adapted viruses such as the pandemic strains.
Characteristic human receptor binding of pandemic viruses and their 
relationship to aerosol transmissibility of pandemic viruses
The 1918 H1N1 subtype is among the most studied viruses. The ability to reconstruct the 
pandemic 1918 H1N1 virus through reverse genetics and test its virulence in ferrets 
permitted a systematic exploration of the roles for various viral genes in its virulence and 
transmissibility [16–18, 66]. Based on the notion of hallmark Asp-190 and Asp-225 residues 
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playing a key role in human-receptor binding of H1N1, single amino acid changes at these 
positions were made on a prototypic pandemic HA (A/South Carolina/1/1918 or SC18). This 
resulted in two variants, NY18 (Asp225→Gly mutant of SC18) and AV18 (Asp-190→Glu 
mutant of NY18). Analysis of the aerosol transmissibility of these viruses in ferrets 
demonstrated that SC18 transmitted efficiently via respiratory droplet, NY18 showed 
transmission but was inefficient and AV18 did not transmit at all [43]. Given that all the 
other genes were identical between SC18, NY18 and AV18, these results showed a clear and 
direct link between altering the RBS of HA and transmissibility of the virus.
The glycan receptor-binding properties of SC18, NY18 and AV18 HA have been 
subsequently characterized in several other studies [23, 59] including recent crystallographic 
analysis of SC18 and NY18 HA binding to LSTa and LSTc [39]. Dose-dependent direct 
binding of SC18, NY18 and AV18 analyzed by precomplexing the HA on a glycan array 
with representative avian and human receptors showed distinct quantitative binding 
properties [59]. While SC18 showed exclusive binding to human receptors with an apparent 
affinity (Kd′) in the picomolar range and minimal binding to avian receptors (Figure 2), 
AV18 showed exclusive binding to avian receptors. NY18 demonstrated intermediate 
binding, with two orders of magnitude lower apparent affinity to human receptors and 
binding to avian receptors in the sub-nanomolar range. That NY18, having Asp-190, 
demonstrated similar binding affinity to both avian and human receptors was surprising 
given that Asp-190 should have enabled NY18 to distinguish between LSTa and LSTc [39, 
42].
SC18, NY18 and AV18 were also analyzed on human tracheal and alveolar sections. Both 
SC18 and NY18 showed apical surface staining of tracheal section in a manner that was 
characteristic of human-adapted HAs. However, SC18 showed a characteristic predominant 
staining of non-ciliated goblet cells when compared to NY18, which stained ciliated cells to 
a greater extent than goblet cells [59]. SC18 showed minimal to no staining of an alveolar 
tissue section, while, consistent with their avian receptor binding properties, NY18 and 
AV18 showed detectable staining of alveolar tissue.
Similar to 1918 H1N1, ferret transmission and glycan-binding studies have been completed 
for the a prototypic strain (A/Albany/6/58 or Alb58) of the 1958 H2N2 pandemic. This virus 
transmitted efficiently via respiratory droplets in ferrets [67]. Dose-dependent glycan array 
binding of Alb58 HA on the glycan array showed high affinity binding to human receptors 
(Kd′ ~ picomolar) [68]. Interestingly, unlike SC18, Alb58 also showed observable binding to 
avian receptors, albeit at a binding affinity that was orders of magnitude lower than that to 
human receptors (Kd′ ~ nanomolar) (Figure 2). Consistent with what was observed for 
SC18, Alb58 HA extensively stained the goblet cells. Additionally, Alb58 stained ciliated 
cells on the apical surface of human tracheal tissue sections as well as alveolar sections [68]. 
Although cross comparison of ferret transmission and glycan binding properties have not 
been performed on the 1967–68 pandemic H3N2 strain, the glycan binding properties of a 
prototypic strain (A/Aichi/1/68 or Aichi68) have been analyzed. Aichi68 shows comparable 
binding to both avian and human receptors with high binding affinity [37].
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More recently, the aerosol transmission in ferrets and glycan-binding properties of the 2009 
H1N1 pandemic strain (A/California/04/09 or Ca0409) were studied [47, 69–72]. The dose-
dependent glycan binding property of Ca0409 was very similar to that of SC18 wherein 
binding was observed exclusively to human receptors. Human tissue of Ca0409, confirmed 
this analysis, and binding of Ca0409 HA was restricted to the goblet cell region on the apical 
surface of the tracheal section similar to SC18 [69]. Notably, however, the binding affinity 
of Ca0409 to human receptors (Kd′ in subnanomolar range) was substantially lower than that 
of SC18 [73]. Consequently, while the Ca0409 virus showed respiratory droplet 
transmission in ferrets, the efficiency of transmission was lower than that of SC18 [69].
Based on the studies summarized above, the HA of pandemic viruses (those that are able to 
achieve respiratory droplet transmission) has distinct glycan binding properties, which 
include high affinity binding to human receptors and a characteristic extensive staining of 
the goblet cells in the apical surface of human tracheal section (Figure 2). On a comparative 
basis, the relative binding affinity of a given HA to human receptors correlates with the 
efficiency of transmission in the ferret model. Indeed, this analysis has demonstrated 
predictive power in the case of H1 [59], H2 [67, 68], H5 [74] and H7 [14, 75–77]. Based on 
these observations, we postulate that the key HA determinant enabling human-to-human 
transmission via the respiratory droplet is the ability of the HA to bind distinct goblet cell 
derived glycans in the upper airways. This is an attribute that is independently measurable 
(through experiments in the ferret) and is a necessary determinant of a virus capable of 
initiating an epidemic or pandemic. Conversely, infection can occur via multiple 
mechanisms, independent of HA–glycan specificity or even that of HA itself, and is also a 
function of the immune status of the individual [78, 79].
Analyzing amino acid changes in the RBS in the context of natural 
sequence evolution of HA
The Ca0409 HA was shown to share high sequence identity, antigenic similarity and 
hallmark residues associated with human receptor binding with SC18 HA [80, 81]. Despite 
these similarities, this HA showed substantially lower affinity binding to human receptors 
relative to that of SC18 HA. A detailed structural analysis of the key residues in the RBS 
revealed key differences in the inter-residue interactions involving positions 219, 227, 222, 
225 and 186 between CA0409, SC18 and seasonal H1N1 HAs [73]. While the interactions 
at these positions were of a hydrophobic nature in SC18 HA, they were ionic in the case of 
seasonal HAs. In contrast to either case, in Ca0409, they were neither hydrophobic nor 
ionic, affecting the positioning of the key Asp-190 residue. Introducing a single amino acid 
change Ile-219→Lys in Ca0409, made these interactions ionic in character, which in turn 
substantially increased human receptor-binding affinity of Ca0409 [73].
Examination of the role of glycosylation on HA in mediating the receptor binding properties 
of HA has extended this analysis [40, 82–84]. Molecular dynamics simulation studies 
predicted that HA–glycans may form interactions near the binding pocket to influence 
receptor binding [82]. Site-directed mutagenesis to knockout glycosylation sites on HA [40, 
85] or modifying structure of N-linked glycans on the virus by enzymatic treatment or 
transgenic cell lines [83] have shown distinct changes in glycan-receptor binding specificity. 
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Loss of glycosylation at a highly conserved sequon was detrimental to receptor binding by 
SC18 and NY18 HA, whereas it did not affect the binding of AV18 HA to avian receptors 
[85]. This observation was explained by analyzing the network of inter-residue interactions 
in the RBS of SC18, NY18, and AV18 and describing the relationship of this network to the 
conserved glycosylation sequon. Removal of HA glycosylation at this sequon had minimal 
impact on the network involving the 220-loop in the RBS of AV18, whereas loss of 
glycosylation disrupted the network within NY18 and SC18 HA [85] (Figure 3).
The aforementioned observations suggest that the presence of hallmark residues cannot be 
directly linked to conferring a specific glycan-binding property to any HA, particularly when 
extrapolating between subtypes. This is evidenced from attempts to introduce hallmark 
amino acids - observed in pandemic H1N1 or H2N2 or H3N2 HA - into H5 HA so as to 
confer so-called gain of function (i.e. aerosol transmissibility in ferrets). None of these H5 
HA mutants showed comparable glycan receptor binding properties of pandemic HAs [40, 
41] or gain of function [74]. It is interesting to view this notion in the context of other 
studies that have approached influenza protein evolution from the perspective of whether 
stabilizing mutations are constrained by epistasis (the notion that stability-affecting 
mutations are tolerated only after occurrence of other compensatory mutations) [86,87]. The 
effects of amino acid changes on glycan receptor binding is more nuanced than those 
affecting overall protein stability and therefore understanding these effects requires a more 
detailed structural analysis of HA–glycan contacts. These structural analyses would need to 
go beyond identifying key residues and account for interactions between key residues (and 
any proximal glycosylation) in the RBS.
These aforementioned key aspects are relevant to recent studies that have demonstrated 
mutations in 2004 (A/Vietnam/1203/04 or Viet04) and 2005 (A/Indonesia/5/05 or Ind05) 
strains of H5N1 HA that have conferred respiratory droplet transmission upon the virus 
strains [29, 86]. Based on these results, several follow-on studies were inclined to fix these 
mutations as so-called hallmark changes for any H5 HA [87]. However, from surveillance 
data, we know that the sequences of HA from current circulating strains of H5 have 
diverged significantly from Viet04 and Indo05 HA. Given this divergence, introducing the 
same set of mutations that resulted in gain of function for Viet04 or Ind05 to currently 
circulating H5 HAs do result in a switch in receptor preference and a gain of function [41]. 
Given the established framework, a detailed structural analysis of RBS of H5 HA was 
completed.
On the basis of phylogenetic ‘closeness’ of H5 to H2 HA, Alb58 HA was chosen as the 
reference human-adapted HA to identify key RBS properties within H5 HA. Four key 
differences were observed. First, the composition of the 130 loop of H2 HA is different from 
H5 HA in that the loop length is shorter by an amino acid. This deletion in the 130-loop in 
H5 HA relative to H2 HA was shown to critically govern the 130-loop. Second, amino acids 
in the ‘base’ of the RBS (such as those in 130-loop at positions 136-138, and 220-loop at 
positions 219-228) are different in H2 than in H5. Third, the ‘top’ of the RBS primarily 
comprising the ‘190-helix’ (residues 188-196) that interacts with the sugars beyond terminal 
Neu5Acα2→6Gal motif in the human receptor are different in H2 than in H5 (specifically at 
positions 188, 189, 192 and 193). Fourth, position 158 is glycosylated in H5 HA but not in 
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H2 HA. Glycosylation at this site has been shown to influence glycan receptor binding 
property of H5 HA [40].
Given these differences, and to understand amino acid changes that would enable the RBS 
of H5 HA match with that of H2, it was important to analyze the network of inter-residue 
interactions within the RBS. This analysis was performed by defining a map known as RBS 
network or RBSN, which showed interactions between RBS residues using a 2-D graph 
(Figure 3). The extent of connectivity was quantified using a network score such that the 
higher the score of an amino acid within the RBS, the more structurally constrained it is to 
mutation. Finally, the differences between the RBS of H2 and H5 HA were captured using a 
new definition termed molecular features (one feature for each difference) which 
incorporated topological definition of glycan receptor in the RBS, RBS residues involved in 
the binding, and their RBSN maps. Four distinct features were identified that together 
constituted a complete description of the H5 RBS.
The molecular feature definition was then mapped onto the phylogenetic sequence analyses 
of H5 HA which showed that many of the clades, including currently circulating clade 1, 
clade 2.2, clade 2.2.1, and clade 7 had already acquired amino acid changes characteristic of 
one or two of Features 1, 3 and 4. However, only a subset of the rapidly evolving and 
currently circulating clades 2.2.1 and 7 had acquired amino acid changes to match Feature 1 
and/or part of Feature 2, which are critical features of the RBS base. From this subset, it was 
demonstrated that select strains required as few as one or two amino acid changes to match 
the requisite features, switch in binding preference and demonstrate human receptor binding 
affinity in the same range as that of pandemic HAs [41].
Concluding remarks
Influenza A viruses have always been viewed as ‘unpredictable’ pathogens where a novel 
subtype could cross species into humans and potentially lead to a widespread pandemic 
outbreak. The concept of switch in glycan-receptor specificity needs to be defined and 
interpreted carefully to enable it to be a useful tool for surveillance and strain 
characterization (Box 1).
Box 1
Outstanding questions
• Is the ratio of α2→6 to α2→3 binding sufficient to characterize glycan receptor 
binding properties of human viruses?
• How do we analyze and interpret HA–glycan receptor binding in the context of 
amino acid changes arising from natural sequence evolution due to host 
selection pressure and epistasis and other changes such as those that affect 
HA:NA balance so as to improve surveillance?
• How can we establish a mechanistic link between HA–glycan interactions in a 
physiological context such as goblet cell binding and the ability of the virus to 
efficiently infect and replicate versus to transmit via aerosol in the human host?
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First, amino acid mutations that confer specific receptor binding properties to a particular 
strain and subtype of HA do not always (or even often) confer the same properties to a HA 
of a different virus. For example, the extent of binding to different receptors appears to vary 
between different subtypes. While human-adapted viruses of group 1 viruses, such as H1N1 
and H2N2, show minimal or low binding affinity to avian receptors, viruses within group 2, 
including H3N2, show comparable binding to both human and avian receptors. These 
studies question the simple definition of switch as ratio of binding to α2→6 vs. α2→3 
glycan receptors and emphasize the importance of identifying and understanding the 
structural and biochemical aspects of HA-glycan receptor interactions. This is particularly 
relevant when looking at subtypes that are rapidly evolving, such as H5N1. We believe that 
the recently developed inter-residue interaction network can potentially be evolved into a 
metric that can assist such surveillance efforts and provide a method to identify strains 
which are evolving towards human receptor specificity. Towards such a goal, additional 
studies need to be undertaken to systematically define network scores and network maps of 
RBS residues of avian-, swine- and human-adapted HAs and identifying a scoring system 
that discriminates the network properties of these HAs.
Second, the analyses of receptor binding properties of HA from multiple subtypes, including 
pandemic strains of H1 and H2, point to characteristic properties such as high affinity 
binding to human receptors and also distinct goblet cell staining patterns, which are at least 
useful descriptors and may also provide insight into a mechanistic link between receptor 
binding preference and aerosol transmissibility. Goblet cells secrete mucins, which can 
potentially assist in the aerosolization of the virus, which in turn might facilitate efficient 
respiratory droplet transmission. Additionally, goblet cell tropism might also shed light on 
why many influenza strains, including H7N9, do not demonstrate efficient respiratory 
droplet transmission even though they have been shown to replicate efficiently in the human 
respiratory tract. Therefore, it is critical to distinguish the roles of glycan specificity in virus 
infection with that of virus transmission.
Third, adaptive changes that affect glycan receptor binding property of HA are often 
accompanied by changes in influenza A neuraminidase enzyme (NA) [88, 89]. The 
relationship between HA binding and NA activity is thought to play a key role in balancing 
the human receptor engagement and viral release from the infected cell to achieve efficient 
respiratory droplet transmission [90, 91]. Glycan-array based methods to probe specificity 
and activity of NA have been developed [90] and can be employed in conjunction with 
measurements of receptor binding properties of HA to improve surveillance.
In summary, through a better understanding of HA–glycan interactions, we can significantly 
improve surveillance methods to advance preparedness and potential countermeasures in the 
event of emergence of novel influenza strains.
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HIGHLIGHTS
• Glycan topology beyond terminal linkage clearly demarcates hemagglutinin 
(HA)–glycan receptor interactions.
• Pandemic virus HAs share characteristic biochemical and physiological receptor 
binding.
• Hallmark mutations in naturally evolving avian HAs led to very different 
receptor binding.
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Figure 1. Glycan receptor conformation and topology in HA RBS
A, Left panel shows the trans conformation adopted by LSTa in the RBS of avian-adapted 
H3 HA (PDB ID: 1MQM). Right panel shows the cis conformation adopted by LSTc in the 
RBS of pandemic H3 HA (PDB ID:2YPG). The RBS is shown in cartoon with side chains 
of key residues labelled and shown. The glycans are shown in the stick representation where 
LSTa and LSTc are respectively colored by atoms (C:blue; O:red; N:dark blue) and 
(C:orange; O:red; N:dark blue). The distinguishing interactions involving the residue at the 
226 position are indicated using dotted lines. B, Left panel shows the topological description 
of avian HA-LSTa glycan complex with where θ is the angle between C-2 atom of Neu5Ac, 
C-1 atom of Gal and C-1 atom of GlcNAc. For θ > 110°, the possible conformations 
sampled by the avian receptor spans a surface on the RBS that resembles a cone (shown in 
dotted lines). Right panel shows the topological description of the pandemic H3 HA-LSTc 
glycan complex where for θ < 100°, LSTc spans a much larger surface on the RBS that 
resembles an umbrella in an open state (θ ~ 100°) to a closed state (θ ~ 45°).
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Figure 2. Glycan receptor binding properties of representative pandemic HAs
Top panels show dose-dependent binding of HA to representative human 
(Neu5Acα2-6Galβ1-4GlcNAcβ1-3Galβ1-4GlcNAcβ) and avian 
(Neu5Acα2-3Galβ1-4GlcNAcβ1-3Galβ1-4GlcNAcβ) receptors. Bottom panels show binding 
of HA to human tracheal tissue sections (HA in green against propidium iodide or PI in red). 
The non-ciliated goblet cell regions on the apical surface of the human tracheal section are 
highlighted in dotted white circles (see references [59, 68] for details).
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Figure 3. Network and molecular features of HA RBS
RBS of SC18 complexed with LSTc is shown along with N-linked trimannosyl core glycan 
structure added at the Asn-91 position using the GlyProt tool (http://www.glycosciences.de/
modeling/glyprot/php/main.php) where the SC18–LSTc cocrystal structure (PDB ID: 
2WR7) was submitted for in silico glycosylation. The side chains of the key residues are 
shown and labeled. The RBSN of representative positions are shown as interconnected 
circular nodes. The nodes are colored with varying shades of red where light pink 
corresponds to residues with lowest RBSN score and bright red corresponds to residues with 
highest RBSN score. The network of interactions involving the glycosylation is indicated as 
a yellow box in the RBSN diagram. The key residue positions along with their RBSN 
provide a more robust approach to investigate amino acid changes for human adaptation of 
HA.
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